Coherus Biosciences | 资产



金融业
股票价格
USD
资产
USD 516.52M
现金及等价物
USD 103.35M
销售成本
USD 2.65M
流动资产
USD 460.96M
流动负债
USD 372.3M
债务
USD 294.93M
股息收益率
0
EBIT
USD -45.44M
EBITDA
USD -44.34M
员工
306
EPS每股收益
USD -0.35
股本和储备
USD 87.77M
销售毛利
USD 4.95M
债务利息支出
USD 2.15M
贷款资金
USD 294.85M
市值
USD 237.8M
净收入
USD -56.57M
营业费用
USD 53.03M
营业利润
USD -45.44M
普通股股本
USD 12K
税前利润
USD -47.4M
销售收入
USD 7.6M
销售和管理费用
USD 26.03M
股票
USD 2.05M
贸易债权人
USD 24.89M
应收帐款人
USD 62.44M


资产 更改 日
AbbVie USD 133.9B 3.28B 2025-09
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Akebia Therapeutics USD 364.15M 18.56M 2025-09
ALKERMES USD 2.33B 76.7M 2025-09
Alnylam Pharmaceuticals USD 4.85B 285.64M 2025-09
Amarin USD 659.81M 10.31M 2025-09
Amgen USD 90.59B 445M 2025-12
Baxter International USD 21.07B 21M 2025-09
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Coherus Biosciences USD 516.52M 77.05M 2025-09
Eli Lilly USD 114.94B 14.01B 2025-09
Fujifilm JPY 5.88T 349.29B 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Merck USD 129.55B 12.02B 2025-09
Myriad Genetics USD 728.1M 50.8M 2025-09
Pacira USD 1.3B 239.68M 2025-09
Perrigo USD 10.08B 10.1M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Teva Pharmaceutical Industries USD 40.75B 892M 2025-12
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09
Xencor USD 868.81M 10.61M 2025-09
Zoetis USD 15.16B 680M 2025-09


Coherus Biosciences 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.